CORBUS PHARMACEUTICALS HOLDI (CRBP) Institutional Ownership Changes & 13F Activity
CORBUS PHARMACEUTICALS HOLDI (CRBP). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Citadel Advisors Llc, Diadema Partners Lp, Dafna Capital Management Llc, Millennium Management Llc, and Adar1 Capital Management, Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Citadel Advisors Llc | Sell | -634,906 | -87.3% | 92,154 | $864.40K | Q2 2026 | Sep 02, 2026 |
| Seven Fleet Capital Management Lp | Sell | -64,255 | -75.0% | 21,432 | $201.03K | Q2 2026 | Aug 17, 2026 |
| Stonepine Capital Management, Llc | Buy | +41,538 | +10.8% | 425,000 | $3.99M | Q2 2026 | Aug 17, 2026 |
| Diadema Partners Lp | Sell | -138,693 | -31.5% | 301,264 | $2.83M | Q2 2026 | Aug 14, 2026 |
| Dafna Capital Management Llc | Buy | +107,773 | — | 107,773 | $1.01M | Q2 2026 | Aug 14, 2026 |
| Millennium Management Llc | Sell | -96,362 | -89.4% | 11,438 | $107.29K | Q2 2026 | Aug 14, 2026 |
| Adar1 Capital Management, Llc | Buy | +90,006 | +27.1% | 421,787 | $3.96M | Q2 2026 | Aug 14, 2026 |
| Susquehanna Portfolio Strategies, Llc | Buy | +75,979 | — | 75,979 | $712.68K | Q2 2026 | Aug 14, 2026 |
| Jane Street Group, Llc | Buy | +65,940 | +90.1% | 139,133 | $1.31M | Q2 2026 | Aug 14, 2026 |
| Charles Schwab Investment Management Inc | Buy | +55,455 | — | 55,455 | $520.17K | Q2 2026 | Aug 14, 2026 |
| Hsbc Holdings Plc | Buy | +55,224 | — | 55,224 | $504.75K | Q2 2026 | Aug 14, 2026 |
| Exome Asset Management Llc | Sell | -49,222 | -21.0% | 184,914 | $1.73M | Q2 2026 | Aug 14, 2026 |
| Prosight Management, Lp | Sell | -47,108 | -6.8% | 650,000 | $6.10M | Q2 2026 | Aug 14, 2026 |
| Susquehanna International Group, Llp | Sell | -40,212 | -12.1% | 293,203 | $2.75M | Q2 2026 | Aug 14, 2026 |
| Driehaus Capital Management Llc | Buy | +38,977 | — | 38,977 | $365.60K | Q2 2026 | Aug 14, 2026 |
| Lmr Partners Llp | Buy | +35,500 | — | 35,500 | $332.99K | Q2 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Sell | -30,248 | -32.5% | 62,863 | $589.65K | Q2 2026 | Aug 14, 2026 |
| Xtx Topco Ltd | Buy | +29,631 | +77.9% | 67,654 | $634.60K | Q2 2026 | Aug 14, 2026 |
| Royal Bank Of Canada | Sell | -26,238 | -87.7% | 3,663 | $35.00K | Q2 2026 | Aug 14, 2026 |
| Caption Management, Llc | Buy | +21,382 | +330.5% | 27,852 | $261.25K | Q2 2026 | Aug 14, 2026 |
| Sectoral Asset Management Inc | Buy | +20,000 | — | 20,000 | $187.60K | Q2 2026 | Aug 14, 2026 |
| Susquehanna Fundamental Investments, Llc | Buy | +18,852 | — | 18,852 | $176.83K | Q2 2026 | Aug 14, 2026 |
| Engineers Gate Manager Lp | Buy | +15,600 | +109.9% | 29,800 | $279.52K | Q2 2026 | Aug 14, 2026 |
| Wells Fargo & Company/Mn | Buy | +13,792 | +31345.5% | 13,836 | $129.78K | Q2 2026 | Aug 14, 2026 |
| Price T Rowe Associates Inc | Buy | +13,699 | +109.0% | 26,271 | $247.00K | Q2 2026 | Aug 14, 2026 |
| Verdad Advisers, Lp | Buy | +13,351 | +26.6% | 63,603 | $596.60K | Q2 2026 | Aug 14, 2026 |
| Barclays Plc | Sell | -12,780 | -61.5% | 8,002 | $75.06K | Q2 2026 | Aug 14, 2026 |
| Brevan Howard Capital Management Lp | Sell | -10,202 | -31.2% | 22,477 | $210.83K | Q2 2026 | Aug 14, 2026 |
| Mirae Asset Global Etfs Holdings Ltd. | Sell | -8,822 | -5.5% | 151,640 | $1.42M | Q2 2026 | Aug 14, 2026 |
| Legal & General Group Plc | Buy | +1,596 | — | 1,596 | $14.97K | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about CRBP activity
Which institutional owners are buying CRBP?
Institutional owners buying CRBP include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in CRBP activity?
"Buy" means an investor increased their reported position in CRBP compared to the prior reporting period. This reflects growing exposure to CORBUS PHARMACEUTICALS HOLDI (CRBP) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in CRBP increasing?
Institutional interest in CRBP can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related CRBP Institutional Insights
- CRBP Overview
- CRBP 13F Institutional Holders
- CRBP Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- CRBP Insider Trading & SEC Form 4 Activity
- CRBP Articles
- Top Institutional Investor Stock Rankings